STAA: STAAR Surgical Co.
About
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Current Value
$26.011 Year Return
Current Value
$26.011 Year Return
Key Details
Market Cap
$1.29B
P/E Ratio
59.67
1Y Stock Return
-22.11%
1Y Revenue Growth
10.01%
Dividend Yield
0.00%
Price to Book
3.0
Strategies that include STAA
Stock's related to STAA
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ALGN | 48.63% | $16.62B | +3.38% | 0.00% |
| XRAY | 47.01% | $3.75B | -39.08% | 3.32% |
| NVST | 43.76% | $3.49B | -15.41% | 0.00% |
| SLP | 40.64% | $554.26M | -28.05% | 0.66% |
| TMCI | 40.26% | $483.43M | -8.71% | 0.00% |
| NVRO | 39.86% | $158.88M | -73.60% | 0.00% |
| ABCL | 39.86% | $800.44M | -37.56% | 0.00% |
| JD | 39.44% | $49.24B | +25.32% | 2.15% |
| LEVI | 39.23% | $6.34B | +2.83% | 3.14% |
| FIGS | 38.69% | $840.56M | -25.56% | 0.00% |
| ADPT | 38.64% | $661.15M | +6.16% | 0.00% |
| COHU | 38.63% | $1.18B | -22.38% | 0.00% |
| BIDU | 38.31% | $25.12B | -24.16% | 0.00% |
| ORC | 38.05% | $615.55M | +6.95% | 18.46% |
| COTY | 37.56% | $6.17B | -34.71% | 0.00% |
| ARR | 37.45% | $1.05B | +8.10% | 16.27% |
| WB | 37.32% | $1.41B | -16.20% | 0.00% |
| CLFD | 37.31% | $398.66M | +4.48% | 0.00% |
| SKLZ | 37.24% | $93.29M | -16.05% | 0.00% |
| WYNN | 37.22% | $10.02B | +5.05% | 1.10% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| IMNN | 0.01% | $10.02M | -22.89% | 0.00% |
| SBUX | -0.01% | $111.45B | -5.15% | 2.37% |
| TMUS | -0.02% | $270.63B | +56.92% | 0.83% |
| WHLM | 0.02% | $17.64M | -29.34% | 0.00% |
| ABBV | 0.04% | $294.35B | +20.07% | 3.72% |
| FRPT | -0.05% | $7.59B | +126.44% | 0.00% |
| VSTA | 0.09% | $204.94M | -39.33% | 0.00% |
| LLY | 0.09% | $692.74B | +23.14% | 0.71% |
| ERIE | -0.09% | $19.39B | +46.23% | 1.23% |
| NXTC | -0.10% | $36.69M | +6.50% | 0.00% |
| AHR | -0.14% | $4.30B | +134.17% | 2.69% |
| KRRO | 0.16% | $436.84M | +20.68% | 0.00% |
| NOC | -0.17% | $71.54B | +4.23% | 1.60% |
| FROG | 0.18% | $3.34B | +11.67% | 0.00% |
| HIG | -0.19% | $33.87B | +51.09% | 1.60% |
| CORZ | -0.19% | $4.60B | +3,201.26% | 0.00% |
| SAVA | -0.19% | $1.35B | +25.50% | 0.00% |
| XBIO | -0.23% | $6.01M | +21.36% | 0.00% |
| CSTE | 0.29% | $134.01M | +2.92% | 0.00% |
| SAFT | -0.30% | $1.25B | +10.17% | 4.36% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MCK | -16.06% | $78.15B | +35.51% | 0.42% |
| ALL | -13.76% | $52.06B | +45.67% | 1.85% |
| MNR | -13.06% | $1.66B | -10.71% | 15.90% |
| WRB | -12.16% | $22.94B | +29.98% | 0.69% |
| COR | -12.06% | $47.48B | +21.20% | 0.86% |
| VRSK | -11.86% | $39.77B | +17.45% | 0.53% |
| PGR | -11.60% | $149.10B | +57.29% | 0.45% |
| CME | -9.70% | $82.76B | +9.21% | 1.98% |
| ADP | -9.41% | $121.23B | +28.69% | 1.89% |
| STG | -8.77% | $35.67M | +7.92% | 0.00% |
| AJG | -8.74% | $64.17B | +17.51% | 0.80% |
| OCX | -8.43% | $42.93M | -36.09% | 0.00% |
| CB | -7.85% | $114.43B | +26.00% | 1.24% |
| JAKK | -7.85% | $303.66M | -7.19% | 0.00% |
| AIZ | -7.71% | $11.24B | +33.00% | 1.31% |
| THG | -7.63% | $5.88B | +36.24% | 2.08% |
| BACK | -7.05% | $1.76M | -32.90% | 0.00% |
| AGO | -6.94% | $4.66B | +37.77% | 1.01% |
| CBOE | -6.86% | $21.46B | +15.84% | 1.11% |
| CAH | -6.58% | $28.64B | +12.14% | 1.70% |
ETF's related to STAA
News
SeekingAlpha
Financial writer cautious on STAAR Surgical due to slower growth & margin pressure.
Yahoo
Investors need to pay close attention to STAAR Surgical (STAA) stock based on the movements in the options market lately.
Yahoo
LAKE FOREST, Calif., November 13, 2024--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with STAAR Management at the upcoming Stephens Annual Investment Conference, which will be held in Nashville, TN.
Yahoo
Evaluate Staar Surgical's (STAA) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Yahoo
Staar Surgical Co (STAA) reports a 10% increase in net sales and robust regional performance despite macroeconomic headwinds.
Yahoo
Last week, you might have seen that STAAR Surgical Company ( NASDAQ:STAA ) released its third-quarter result to the...
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.